FDA approves first RSV vaccine for at-risk adults in their 50s
The Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus down to age 50 years old, ...
The Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus down to age 50 years old, ...
